Venous thromboembolism in neurologic disease.

作者: Michael J. Schneck

DOI: 10.1016/B978-0-7020-4086-3.00020-5

关键词: Intensive care medicinePulmonary embolismVenous thromboembolismNeurologic diseaseInferior vena cavaThrombosisIn patientIncreased riskMedicineSubcutaneous heparin

摘要: Abstract Patients with neurologic disease are at high risk of venous thromboembolism (VTE) because relative immobility. They also increased due to the presence a hypercoagulable state. spinal cord injuries, brain tumors, and strokes particularly extra vigilance is needed in these patients. Because VTE very common hospitalized neurosurgical patients, mechanical thromboprophylaxis indicated virtually all Pharmacologic prophylaxis either subcutaneous heparin or low molecular heparinoids should be given high-risk patients provided there no major contraindications. The concern would bleeding but some alternate drugs must considered thrombosis (i.e., context heparin-induced thrombocytopenia). immediate long-term treatment offull dose anticoagulation for may not appropriate as therapy represents balance between risks related anticoagulant versus recurrent events. An inferior vena cava (IVC) filter another option necessarily best choice most Given diseases, early recognition by clinicians signs symptoms essential.

参考文章(105)
Om P Sharma, Michael F Oswanski, Rusin J Joseph, Peter Tonui, Libby Westrick Pa-C, Shekhar S Raj, Thomas Tatchell, Phillip J Waite, Angela Gandaio, None, Venous thromboembolism in trauma patients. American Surgeon. ,vol. 73, pp. 1173- 1180 ,(2007) , 10.1177/000313480707301121
B E Burbridge, A Rajput, J K Wallace, L McCulloch, Doppler ultrasonographic examination of the leg veins of patients with Parkinson disease Journal of Psychiatry & Neuroscience. ,vol. 24, pp. 338- 340 ,(1999)
J. R. PERRY, J. A. JULIAN, N. J. LAPERRIERE, W. GEERTS, G. AGNELLI, L. R. ROGERS, M. G. MALKIN, R. SAWAYA, R. BAKER, A. FALANGA, S. PARPIA, T. FINCH, M. N. LEVINE, PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma Journal of Thrombosis and Haemostasis. ,vol. 8, pp. 1959- 1965 ,(2010) , 10.1111/J.1538-7836.2010.03973.X
Wilson Z. Ray, Russel G. Strom, Spiros L. Blackburn, William W. Ashley, Gregorio A. Sicard, Keith M. Rich, Incidence of deep venous thrombosis after subarachnoid hemorrhage : Clinical article Journal of Neurosurgery. ,vol. 110, pp. 1010- 1014 ,(2009) , 10.3171/2008.9.JNS08107
Thomas J. Semrad, Robert O'Donnell, Ted Wun, Helen Chew, Danielle Harvey, Hong Zhou, Richard H. White, Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. Journal of Neurosurgery. ,vol. 106, pp. 601- 608 ,(2007) , 10.3171/JNS.2007.106.4.601
Michael E. Sughrue, Martin J. Rutkowski, Gopal Shangari, H. Quinn Chang, Andrew T. Parsa, Mitchel S. Berger, Michael W. McDermott, Risk factors for the development of serious medical complications after resection of meningiomas: Clinical article Journal of Neurosurgery. ,vol. 114, pp. 697- 704 ,(2011) , 10.3171/2010.6.JNS091974
Scott H Norwood, Clyde E McAuley, John D Berne, Van L Vallina, D Brent Kerns, Thomas W Grahm, Kevin Short, Jerry W McLarty, Prospective Evaluation of the Safety of Enoxaparin Prophylaxis for Venous Thromboembolism in Patients With Intracranial Hemorrhagic Injuries Archives of Surgery. ,vol. 137, pp. 696- 702 ,(2002) , 10.1001/ARCHSURG.137.6.696